Abstract | BACKGROUND: AIM: To determine esophageal expression and the genetic variation of the Myo9B gene in the RE-BE-EAC cascade. METHODS:
DNA from 886 Caucasian participants (198 non-reflux controls, 305 RE, 254 BE, 129 EAC) was collected for the determination of the Myo9B gene polymorphism (rs2305764). Esophageal Myo9B expression was determined on biopsies from normal, RE, BE and EAC epithelium. RESULTS: Genotype G/G was more common in BE (p = 0.032) and EAC (p = 0.046), but not in RE (p = 0.126) compared with the control group. Cytoplasmic Myo9B expression was determined in RE, BE and EAC, but most prominent in epithelial cells of BE and EAC. CONCLUSIONS: Genetic variation of Myo9B may play a role in the etiology of BE and EAC by increasing the permeability of the epithelial barrier.
|
Authors | Vivianda Menke, Katinka P M Van Zoest, Leon M G Moons, Raymond G J Pot, Peter D Siersema, Ernst J Kuipers, Johannes G Kusters |
Journal | Scandinavian journal of gastroenterology
(Scand J Gastroenterol)
Vol. 47
Issue 12
Pg. 1422-8
(Dec 2012)
ISSN: 1502-7708 [Electronic] England |
PMID | 22954106
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adenocarcinoma
(genetics, metabolism)
- Adult
- Aged
- Barrett Esophagus
(genetics, metabolism)
- Case-Control Studies
- Chi-Square Distribution
- Confidence Intervals
- Esophageal Neoplasms
(genetics, metabolism)
- Esophagitis, Peptic
(genetics, metabolism)
- Female
- Genetic Predisposition to Disease
- Genotype
- Humans
- Male
- Middle Aged
- Myosins
(genetics, metabolism)
- Odds Ratio
- Polymorphism, Single Nucleotide
- Precancerous Conditions
(genetics, metabolism)
|